Capricor Therapeutics (NASDAQ:CAPR) Price Target Lowered to $29.00 at Jones Trading
Capricor Therapeutics (NASDAQ:CAPR – Get Free Report) had its target price decreased by equities research analysts at Jones Trading from $40.00 to $29.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Jones Trading’s price objective would indicate a potential upside of 184.87% from the […]
Capricor Therapeutics (NASDAQ:CAPR – Get Free Report) had its target price decreased by equities research analysts at Jones Trading from $40.00 to $29.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Jones Trading’s price objective would indicate a potential upside of 184.87% from the […]
